Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series
Immune checkpoint inhibitors (ICIs) are established treatments for various malignancies, including lung, kidney, and colorectal cancers. However, their broad use has led to an increase in immune-related adverse events (irAEs), with thyroiditis, colitis, and pneumonitis being the most common. Hemopha...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Open Exploration Publishing Inc.
2025-11-01
|
| סדרה: | Exploration of Targeted Anti-tumor Therapy |
| נושאים: | |
| גישה מקוונת: | https://www.explorationpub.com/uploads/Article/A1002347/1002347.pdf |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|